Rheumatoid Arthritis
Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet o...
Ausführliche Beschreibung
Autor*in: |
Leeb, Burkhard F. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
1998 |
---|
Schlagwörter: |
---|
Anmerkung: |
© Adis International Limited 1998 |
---|
Übergeordnetes Werk: |
Enthalten in: Disease Management & Health Outcomes - Springer International Publishing, 1997, 4(1998), 6 vom: Dez., Seite 315-324 |
---|---|
Übergeordnetes Werk: |
volume:4 ; year:1998 ; number:6 ; month:12 ; pages:315-324 |
Links: |
---|
DOI / URN: |
10.2165/00115677-199804060-00002 |
---|
Katalog-ID: |
SPR035650834 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR035650834 | ||
003 | DE-627 | ||
005 | 20230519112259.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s1998 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2165/00115677-199804060-00002 |2 doi | |
035 | |a (DE-627)SPR035650834 | ||
035 | |a (SPR)00115677-199804060-00002-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Leeb, Burkhard F. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rheumatoid Arthritis |
264 | 1 | |c 1998 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Adis International Limited 1998 | ||
520 | |a Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. | ||
650 | 4 | |a Rheumatoid Arthritis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Adis International Limited |7 (dpeaa)DE-He213 | |
650 | 4 | |a Early Rheumatoid Arthritis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Reactive Arthritis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Toid Arthritis |7 (dpeaa)DE-He213 | |
700 | 1 | |a Weber, Katharina |4 aut | |
700 | 1 | |a Smolen, Josef S. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Disease Management & Health Outcomes |d Springer International Publishing, 1997 |g 4(1998), 6 vom: Dez., Seite 315-324 |w (DE-627)SPR035648813 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:1998 |g number:6 |g month:12 |g pages:315-324 |
856 | 4 | 0 | |u https://dx.doi.org/10.2165/00115677-199804060-00002 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 4 |j 1998 |e 6 |c 12 |h 315-324 |
author_variant |
b f l bf bfl k w kw j s s js jss |
---|---|
matchkey_str |
leebburkhardfweberkatharinasmolenjosefs:1998----:huaodr |
hierarchy_sort_str |
1998 |
publishDate |
1998 |
allfields |
10.2165/00115677-199804060-00002 doi (DE-627)SPR035650834 (SPR)00115677-199804060-00002-e DE-627 ger DE-627 rakwb eng Leeb, Burkhard F. verfasserin aut Rheumatoid Arthritis 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1998 Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. Rheumatoid Arthritis (dpeaa)DE-He213 Adis International Limited (dpeaa)DE-He213 Early Rheumatoid Arthritis (dpeaa)DE-He213 Reactive Arthritis (dpeaa)DE-He213 Toid Arthritis (dpeaa)DE-He213 Weber, Katharina aut Smolen, Josef S. aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 4(1998), 6 vom: Dez., Seite 315-324 (DE-627)SPR035648813 nnns volume:4 year:1998 number:6 month:12 pages:315-324 https://dx.doi.org/10.2165/00115677-199804060-00002 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 4 1998 6 12 315-324 |
spelling |
10.2165/00115677-199804060-00002 doi (DE-627)SPR035650834 (SPR)00115677-199804060-00002-e DE-627 ger DE-627 rakwb eng Leeb, Burkhard F. verfasserin aut Rheumatoid Arthritis 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1998 Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. Rheumatoid Arthritis (dpeaa)DE-He213 Adis International Limited (dpeaa)DE-He213 Early Rheumatoid Arthritis (dpeaa)DE-He213 Reactive Arthritis (dpeaa)DE-He213 Toid Arthritis (dpeaa)DE-He213 Weber, Katharina aut Smolen, Josef S. aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 4(1998), 6 vom: Dez., Seite 315-324 (DE-627)SPR035648813 nnns volume:4 year:1998 number:6 month:12 pages:315-324 https://dx.doi.org/10.2165/00115677-199804060-00002 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 4 1998 6 12 315-324 |
allfields_unstemmed |
10.2165/00115677-199804060-00002 doi (DE-627)SPR035650834 (SPR)00115677-199804060-00002-e DE-627 ger DE-627 rakwb eng Leeb, Burkhard F. verfasserin aut Rheumatoid Arthritis 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1998 Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. Rheumatoid Arthritis (dpeaa)DE-He213 Adis International Limited (dpeaa)DE-He213 Early Rheumatoid Arthritis (dpeaa)DE-He213 Reactive Arthritis (dpeaa)DE-He213 Toid Arthritis (dpeaa)DE-He213 Weber, Katharina aut Smolen, Josef S. aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 4(1998), 6 vom: Dez., Seite 315-324 (DE-627)SPR035648813 nnns volume:4 year:1998 number:6 month:12 pages:315-324 https://dx.doi.org/10.2165/00115677-199804060-00002 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 4 1998 6 12 315-324 |
allfieldsGer |
10.2165/00115677-199804060-00002 doi (DE-627)SPR035650834 (SPR)00115677-199804060-00002-e DE-627 ger DE-627 rakwb eng Leeb, Burkhard F. verfasserin aut Rheumatoid Arthritis 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1998 Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. Rheumatoid Arthritis (dpeaa)DE-He213 Adis International Limited (dpeaa)DE-He213 Early Rheumatoid Arthritis (dpeaa)DE-He213 Reactive Arthritis (dpeaa)DE-He213 Toid Arthritis (dpeaa)DE-He213 Weber, Katharina aut Smolen, Josef S. aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 4(1998), 6 vom: Dez., Seite 315-324 (DE-627)SPR035648813 nnns volume:4 year:1998 number:6 month:12 pages:315-324 https://dx.doi.org/10.2165/00115677-199804060-00002 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 4 1998 6 12 315-324 |
allfieldsSound |
10.2165/00115677-199804060-00002 doi (DE-627)SPR035650834 (SPR)00115677-199804060-00002-e DE-627 ger DE-627 rakwb eng Leeb, Burkhard F. verfasserin aut Rheumatoid Arthritis 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1998 Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. Rheumatoid Arthritis (dpeaa)DE-He213 Adis International Limited (dpeaa)DE-He213 Early Rheumatoid Arthritis (dpeaa)DE-He213 Reactive Arthritis (dpeaa)DE-He213 Toid Arthritis (dpeaa)DE-He213 Weber, Katharina aut Smolen, Josef S. aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 4(1998), 6 vom: Dez., Seite 315-324 (DE-627)SPR035648813 nnns volume:4 year:1998 number:6 month:12 pages:315-324 https://dx.doi.org/10.2165/00115677-199804060-00002 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 4 1998 6 12 315-324 |
language |
English |
source |
Enthalten in Disease Management & Health Outcomes 4(1998), 6 vom: Dez., Seite 315-324 volume:4 year:1998 number:6 month:12 pages:315-324 |
sourceStr |
Enthalten in Disease Management & Health Outcomes 4(1998), 6 vom: Dez., Seite 315-324 volume:4 year:1998 number:6 month:12 pages:315-324 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Rheumatoid Arthritis Adis International Limited Early Rheumatoid Arthritis Reactive Arthritis Toid Arthritis |
isfreeaccess_bool |
false |
container_title |
Disease Management & Health Outcomes |
authorswithroles_txt_mv |
Leeb, Burkhard F. @@aut@@ Weber, Katharina @@aut@@ Smolen, Josef S. @@aut@@ |
publishDateDaySort_date |
1998-12-01T00:00:00Z |
hierarchy_top_id |
SPR035648813 |
id |
SPR035650834 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035650834</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519112259.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1998 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00115677-199804060-00002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035650834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00115677-199804060-00002-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Leeb, Burkhard F.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rheumatoid Arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1998</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Limited 1998</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatoid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adis International Limited</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Early Rheumatoid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reactive Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber, Katharina</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smolen, Josef S.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Disease Management & Health Outcomes</subfield><subfield code="d">Springer International Publishing, 1997</subfield><subfield code="g">4(1998), 6 vom: Dez., Seite 315-324</subfield><subfield code="w">(DE-627)SPR035648813</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:1998</subfield><subfield code="g">number:6</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:315-324</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00115677-199804060-00002</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">1998</subfield><subfield code="e">6</subfield><subfield code="c">12</subfield><subfield code="h">315-324</subfield></datafield></record></collection>
|
author |
Leeb, Burkhard F. |
spellingShingle |
Leeb, Burkhard F. misc Rheumatoid Arthritis misc Adis International Limited misc Early Rheumatoid Arthritis misc Reactive Arthritis misc Toid Arthritis Rheumatoid Arthritis |
authorStr |
Leeb, Burkhard F. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR035648813 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
Rheumatoid Arthritis Rheumatoid Arthritis (dpeaa)DE-He213 Adis International Limited (dpeaa)DE-He213 Early Rheumatoid Arthritis (dpeaa)DE-He213 Reactive Arthritis (dpeaa)DE-He213 Toid Arthritis (dpeaa)DE-He213 |
topic |
misc Rheumatoid Arthritis misc Adis International Limited misc Early Rheumatoid Arthritis misc Reactive Arthritis misc Toid Arthritis |
topic_unstemmed |
misc Rheumatoid Arthritis misc Adis International Limited misc Early Rheumatoid Arthritis misc Reactive Arthritis misc Toid Arthritis |
topic_browse |
misc Rheumatoid Arthritis misc Adis International Limited misc Early Rheumatoid Arthritis misc Reactive Arthritis misc Toid Arthritis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Disease Management & Health Outcomes |
hierarchy_parent_id |
SPR035648813 |
hierarchy_top_title |
Disease Management & Health Outcomes |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)SPR035648813 |
title |
Rheumatoid Arthritis |
ctrlnum |
(DE-627)SPR035650834 (SPR)00115677-199804060-00002-e |
title_full |
Rheumatoid Arthritis |
author_sort |
Leeb, Burkhard F. |
journal |
Disease Management & Health Outcomes |
journalStr |
Disease Management & Health Outcomes |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1998 |
contenttype_str_mv |
txt |
container_start_page |
315 |
author_browse |
Leeb, Burkhard F. Weber, Katharina Smolen, Josef S. |
container_volume |
4 |
format_se |
Elektronische Aufsätze |
author-letter |
Leeb, Burkhard F. |
doi_str_mv |
10.2165/00115677-199804060-00002 |
title_sort |
rheumatoid arthritis |
title_auth |
Rheumatoid Arthritis |
abstract |
Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. © Adis International Limited 1998 |
abstractGer |
Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. © Adis International Limited 1998 |
abstract_unstemmed |
Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems. © Adis International Limited 1998 |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
container_issue |
6 |
title_short |
Rheumatoid Arthritis |
url |
https://dx.doi.org/10.2165/00115677-199804060-00002 |
remote_bool |
true |
author2 |
Weber, Katharina Smolen, Josef S. |
author2Str |
Weber, Katharina Smolen, Josef S. |
ppnlink |
SPR035648813 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.2165/00115677-199804060-00002 |
up_date |
2024-07-03T15:31:05.131Z |
_version_ |
1803572388991860736 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035650834</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519112259.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1998 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00115677-199804060-00002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035650834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00115677-199804060-00002-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Leeb, Burkhard F.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rheumatoid Arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1998</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Limited 1998</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Rheumatoid arthritis is a common inflammatory joint disorder, with a prevalence of about 1% in the general population. It shows high variability with respect to its course and prognosis. In typical cases an insidious onset of symmetrical synovitis of the small joints of the hands and feet occurs, accompanied by symptoms such as morning stiffness, weakness and fatigue. Besides clinical findings, laboratory tests and imaging techniques are other cornerstones for diagnosis of rheumatoid arthritis. Rheumatoid arthritis is anything but a benign disease, potentially leading to disability, chronic pain, morbidity and even early death. Recent studies provide strong evidence that early diagnosis and treatment are crucial for the prognosis of the disease. In recent years, great efforts have been made to detect and establish diagnostic, as well as prognostic, parameters for rheumatoid arthritis. Whereas the reliability of new diagnostic parameters has not been proven conclusively, reliable prognostic factors have been established that may help in identifying patients at high risk for progressive, disabling disease. These risk factors include: high number of joints involved at onset, marked disability, elevated acute phase reactants, a positive finding for rheumatoid factor, female gender, advanced age, presence of certain HLA class II antigens, early x-ray changes, low bone mineral density and job-related physical requirements. As the established classification criteria cover longstanding disease, but not the early stages, it appears necessary to establish a new set of diagnostic criteria for early rheumatoid arthritis. In the case of newly diagnosed rheumatoid arthritis, more attention should be paid to well-known risk factors. This allows a risk profile to be established for individual patients, which may facilitate decisions regarding therapy. A better outcome of rheumatoid arthritis would not only be advantageous for individual patients, but would also result in reduced costs for healthcare systems.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatoid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adis International Limited</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Early Rheumatoid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reactive Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber, Katharina</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smolen, Josef S.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Disease Management & Health Outcomes</subfield><subfield code="d">Springer International Publishing, 1997</subfield><subfield code="g">4(1998), 6 vom: Dez., Seite 315-324</subfield><subfield code="w">(DE-627)SPR035648813</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:1998</subfield><subfield code="g">number:6</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:315-324</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00115677-199804060-00002</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">1998</subfield><subfield code="e">6</subfield><subfield code="c">12</subfield><subfield code="h">315-324</subfield></datafield></record></collection>
|
score |
7.3991594 |